Gasser R - Search Results

1

Pharmacogenetic analysis of adverse drug effect reveals genetic variant for susceptibility to liver toxicity.

Acuña G, Foernzler D, Leong D, Rabbia M, Smit R, Dorflinger E, Gasser R, Hoh J, Ott J, Borroni E, To Z, Thompson A, Li J, Hashimoto L, Lindpaintner K. Acuña G, et al. Among authors: gasser r. Pharmacogenomics J. 2002;2(5):327-34. doi: 10.1038/sj.tpj.6500123. Pharmacogenomics J. 2002. PMID: 12439739

2

A preclinical re-evaluation of the safety profile of tolcapone.

Borroni E, Cesura AM, Gatti S, Gasser R. Borroni E, et al. Among authors: gasser r. Funct Neurol. 2001;16(4 Suppl):125-34. Funct Neurol. 2001. PMID: 11996507 Review. No abstract available.

3

RO4938581, a novel cognitive enhancer acting at GABAA alpha5 subunit-containing receptors.

Ballard TM, Knoflach F, Prinssen E, Borroni E, Vivian JA, Basile J, Gasser R, Moreau JL, Wettstein JG, Buettelmann B, Knust H, Thomas AW, Trube G, Hernandez MC. Ballard TM, et al. Among authors: gasser r. Psychopharmacology (Berl). 2009 Jan;202(1-3):207-23. doi: 10.1007/s00213-008-1357-7. Epub 2008 Oct 21. Psychopharmacology (Berl). 2009. PMID: 18936916

4

Lack of interaction between tolcapone and tolbutamide in healthy volunteers.

Jorga KM, Fotteler B, Gasser R, Banken L, Birnboeck H. Jorga KM, et al. Among authors: gasser r. J Clin Pharmacol. 2000 May;40(5):544-51. doi: 10.1177/00912700022009161. J Clin Pharmacol. 2000. PMID: 10806608 Clinical Trial.

5

Modulation of gene and protein expression by carbon tetrachloride in the rat liver.

Fountoulakis M, de Vera MC, Crameri F, Boess F, Gasser R, Albertini S, Suter L. Fountoulakis M, et al. Among authors: gasser r. Toxicol Appl Pharmacol. 2002 Aug 15;183(1):71-80. doi: 10.1006/taap.2002.9460. Toxicol Appl Pharmacol. 2002. PMID: 12217644

6

Metabolism and excretion of tolcapone, a novel inhibitor of catechol-O-methyltransferase.

Jorga K, Fotteler B, Heizmann P, Gasser R. Jorga K, et al. Among authors: gasser r. Br J Clin Pharmacol. 1999 Oct;48(4):513-20. doi: 10.1046/j.1365-2125.1999.00036.x. Br J Clin Pharmacol. 1999. PMID: 10583021 Free PMC article. Clinical Trial.

7

Discriminating different classes of toxicants by transcript profiling.

Steiner G, Suter L, Boess F, Gasser R, de Vera MC, Albertini S, Ruepp S. Steiner G, et al. Among authors: gasser r. Environ Health Perspect. 2004 Aug;112(12):1236-48. doi: 10.1289/txg.7036. Environ Health Perspect. 2004. PMID: 15345370 Free PMC article.

8

Absorption, excretion, and metabolism of the endothelin receptor antagonist bosentan in healthy male subjects.

Weber C, Gasser R, Hopfgartner G. Weber C, et al. Among authors: gasser r. Drug Metab Dispos. 1999 Jul;27(7):810-5. Drug Metab Dispos. 1999. PMID: 10383925

9

Gene expression in two hepatic cell lines, cultured primary hepatocytes, and liver slices compared to the in vivo liver gene expression in rats: possible implications for toxicogenomics use of in vitro systems.

Boess F, Kamber M, Romer S, Gasser R, Muller D, Albertini S, Suter L. Boess F, et al. Among authors: gasser r. Toxicol Sci. 2003 Jun;73(2):386-402. doi: 10.1093/toxsci/kfg064. Epub 2003 Mar 25. Toxicol Sci. 2003. PMID: 12657743

10

Use of transgenic cell lines in mechanistic studies of drug metabolism.

Gasser R, Funk C, Matzinger P, Klemisch W, Viger-Chougnet A. Gasser R, et al. Toxicol In Vitro. 1999 Aug-Oct;13(4-5):625-32. doi: 10.1016/s0887-2333(99)00035-1. Toxicol In Vitro. 1999. PMID: 20654526

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,100 results

Search Page

Filters